Why the study?
Does the metabolic score for insulin resistance (METS-IR) predict major adverse cardiovascular events in patients after coronary artery bypass surgery?
Does the metabolic score for insulin resistance (METS-IR) predict major adverse cardiovascular events in patients after coronary artery bypass surgery?
METS-IR is a simple and reliable indicator for risk stratification of MACE in patients after CABG.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: